Fagron

Regulated information: Disclosure of a transparency notification from BlackRock, Inc.

16 Oct 2026 12:00:00 By Nasdaq GlobeNewswire

Regulated information – inside information: Fagron delivers strong 23.2% revenue growth in the third quarter to €281.3 million and confirms FY guidance range

08 Oct 2026 01:00:00 By Nasdaq GlobeNewswire

Regulated information: Disclosure of a transparency notification from BlackRock, Inc.

29 Sep 2026 12:00:00 By Nasdaq GlobeNewswire

Regulated information: Fagron increases share capital through exercise subscription rights

21 Sep 2026 13:07:51 By Nasdaq GlobeNewswire

Inside information: Fagron announces the completion of the acquisition of University Compounding Pharmacy in North America

12 Jan 2026 01:00:00 By Nasdaq GlobeNewswire

Disclosure of notification received from BNP Paribas

09 Jan 2026 11:40:00 By Nasdaq GlobeNewswire

Fagron announces the completion of Purifarma

06 Jan 2026 01:00:00 By Nasdaq GlobeNewswire

Fagron accelerates global expansion with two strategic acquisitions and a key North American licensing milestone

19 Dec 2025 01:00:00 By Nasdaq GlobeNewswire

Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business

24 Nov 2025 01:00:00 By Nasdaq GlobeNewswire

Fagron completes share buy-back program

14 Nov 2025 12:39:30 By Nasdaq GlobeNewswire

Fagron’s share buy-back program: Weekly update

07 Nov 2025 12:39:15 By Nasdaq GlobeNewswire

Fagron’s share buy-back program: Weekly update

31 Oct 2025 13:25:33 By Nasdaq GlobeNewswire

Fagron’s share buy-back program: Weekly update

24 Oct 2025 12:22:11 By Nasdaq GlobeNewswire

Fagron’s share buy-back program: Weekly update

17 Oct 2025 12:13:28 By Nasdaq GlobeNewswire

Fagron reports solid third quarter performance with 6.4% revenue growth and confirms full year outlook

09 Oct 2025 01:00:00 By Nasdaq GlobeNewswire

Fagron receives Brazilian antitrust clearance for Purifarma and Injeplast acquisitions

06 Oct 2025 01:00:00 By Nasdaq GlobeNewswire

Fagron increases share capital through exercise subscription rights

29 Sep 2025 13:00:00 By Nasdaq GlobeNewswire

Fagron announces the acquisition of UCP in North America and FDA inspection update

25 Sep 2025 01:00:00 By Nasdaq GlobeNewswire

Disclosure of notification received from Mawer

05 Sep 2025 11:40:00 By Nasdaq GlobeNewswire

Fagron delivers strong performance with 11% topline growth and 12% increase in REBITDA for H1 2025

31 Jul 2025 01:00:00 By Nasdaq GlobeNewswire